Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans

Diabetes

Volumn 51, Issue 6, 2002, Pages 1867-1875

  Carpentier, Andre ^a   Patterson, Bruce W ^b   Leung, Nathalie ^a   Lewis, Gary F ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN CLEARANCE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0036260039     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.6.1867     Document Type: Article

References (52)

1. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes
2. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans
3. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
4. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study
5. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: The Insulin Resistance Atherosclerosis Study
6. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans
7. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulindependent diabetes mellitus
8. Triglyceride is the major atherogenic lipid in NIDDM
9. Acute effects of insulin in the control of VLDL production in humans: Implications for the insulin-resistant state
10. Fatty acid regulation of very low density lipoprotein production
11. Mechanisms of hepatic VLDL overproduction in insulin resistance: Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model
12. In vivo regulation of lipolysis in humans
13. Insulin resistance and cardiovascular disease
14. Report of the expert comittee on the diagnosis and classification of diabetes mellitus
15. 5]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans
16. Assessment of insulin sensitivity in vivo
17. Method of insulin administration has no effect on insulin sensitivity estimates from the insulin-modified minimal model protocol
18. Effect of portal vs. systemic insulin delivery in pancreas transplantation on insulin action and VLDL metabolism
19. Insulin regulation of lipolysis in nondiabetic and IDDM subjects
20. Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat)
21. Improved method for quantitation of B apoprotein in plasma lipoproteins by electroimmunoassay
22. Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: Structural studies
23. Use of stable isotopically labeled tracers to measure very low density lipoproteintriglyceride turnover
24. MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test
25. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor 4alpha/MODY1 gene
26. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
27. Estimation of insulin secretion rates from C-peptide levels: Comparison of individual and standard kinetic parameters for C-peptide clearance
28. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: A stable isotope study
29. Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects
30. Long-term association of cardiovascular risk factors with impaired insulin secretion and insulin resistance
31. Influence of obesity on the metabolism of apolipoprotein B in humans
32. Contribution of glucose tolerance and plasma insulin levels to the relationships between body fat distribution and plasma lipoprotein levels in women
33. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity
34. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men
35. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity
36. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: Relevance to variation in risk of diabetes and coronary disease
37. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
38. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men
39. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance
40. Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
41. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: Is cellular insulin resistance a secondary phenomenon?
42. Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance
43. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans
44. Dose-response characteristics for effects of insulin on production and utilization of glucose in man
45. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition
46. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: Implications for the control of fat storage and fat mobilization
47. Studies of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: Lack of influence of body weight or plasma insulin
48. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes
49. Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men
50. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: Effects of obesity and non-insulin-dependent diabetes mellitus
51. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man
52. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats